Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.
2.

Glutamate metabotropic receptors as targets for drug therapy in epilepsy.

Moldrich RX, Chapman AG, De Sarro G, Meldrum BS.

Eur J Pharmacol. 2003 Aug 22;476(1-2):3-16. Review.

PMID:
12969743
3.

Pharmacological agents acting at subtypes of metabotropic glutamate receptors.

Schoepp DD, Jane DE, Monn JA.

Neuropharmacology. 1999 Oct;38(10):1431-76. Review.

PMID:
10530808
4.
5.

Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Kew JN, Kemp JA.

Psychopharmacology (Berl). 2005 Apr;179(1):4-29. Epub 2005 Feb 25. Review. Erratum in: Psychopharmacology (Berl). 2005 Oct;182(2):320.

PMID:
15731895
6.

Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.

Chaki S.

Eur J Pharmacol. 2010 Aug 10;639(1-3):59-66. doi: 10.1016/j.ejphar.2009.12.041. Epub 2010 Apr 2. Review.

PMID:
20371240
7.

Targeting of metabotropic glutamate receptors for the treatment of schizophrenia.

Chaki S, Hikichi H.

Curr Pharm Des. 2011;17(2):94-102. Review.

PMID:
21355835
8.

[The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].

Chaki S.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2012 Aug;32(4):219-26. Review. Japanese.

PMID:
23012890
9.

Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition.

Marek GJ.

Eur J Pharmacol. 2010 Aug 10;639(1-3):81-90. doi: 10.1016/j.ejphar.2010.02.058. Epub 2010 Apr 2. Review.

PMID:
20371229
10.

[Targeting metabotropic glutamate receptors to develop novel antipsychotics].

Chaki S, Yoshida S, Okuyama S.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Nov;30(5-6):207-13. Review. Japanese.

PMID:
21226317
11.

Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.

Litim N, Morissette M, Di Paolo T.

Neuropharmacology. 2017 Mar 15;115:166-179. doi: 10.1016/j.neuropharm.2016.03.036. Epub 2016 Apr 4. Review.

PMID:
27055772
12.

Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic?

Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V.

Neurochem Int. 2012 Sep;61(4):559-65. doi: 10.1016/j.neuint.2012.01.017. Epub 2012 Jan 25. Review.

PMID:
22306345
13.

Metabotropic glutamate receptors and the control of chronic pain.

Chiechio S, Nicoletti F.

Curr Opin Pharmacol. 2012 Feb;12(1):28-34. doi: 10.1016/j.coph.2011.10.010. Epub 2011 Oct 29. Review.

PMID:
22040745
14.

mGlu5 receptor antagonists: a novel class of anxiolytics?

Spooren W, Gasparini F.

Drug News Perspect. 2004 May;17(4):251-7. Review.

PMID:
15334174
15.

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

Maksymetz J, Moran SP, Conn PJ.

Mol Brain. 2017 Apr 26;10(1):15. doi: 10.1186/s13041-017-0293-z. Review.

16.

Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.

Sheffler DJ, Pinkerton AB, Dahl R, Markou A, Cosford ND.

ACS Chem Neurosci. 2011 Aug 17;2(8):382-93. doi: 10.1021/cn200008d. Epub 2011 Apr 12. Review.

17.

mGluR2 positive allosteric modulators: a patent review (2009 - present).

Trabanco AA, Cid JM.

Expert Opin Ther Pat. 2013 May;23(5):629-47. doi: 10.1517/13543776.2013.777043. Epub 2013 Mar 2. Review.

PMID:
23452205
18.

Metabotropic glutamate receptors: their therapeutic potential in anxiety.

Spooren W, Lesage A, Lavreysen H, Gasparini F, Steckler T.

Curr Top Behav Neurosci. 2010;2:391-413. Review.

PMID:
21309118
19.

In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article.

Kuhn R, Pagano A, Stoehr N, Vranesic I, Flor PJ, Lingenhöhl K, Spooren W, Gentsch C, Vassout A, Pilc A, Gasparini F.

Amino Acids. 2002;23(1-3):207-11. Review.

PMID:
12373539
20.

Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 - present).

Celanire S, Sebhat I, Wichmann J, Mayer S, Schann S, Gatti S.

Expert Opin Ther Pat. 2015 Jan;25(1):69-90. doi: 10.1517/13543776.2014.983899. Epub 2014 Dec 1. Review.

PMID:
25435285

Supplemental Content

Support Center